Downregulation of the elongation of long-chain fatty acid family members 3 and 6 (ELOVL3 and ELOVL6) in AD lesions is consistent with the expression of long-chain fatty acid-containing LPC [34]. The gene discussed is ELOVL6; the disease is Alzheimer disease.